362525-67-5

Basic information

• Product Name: Imidazo[1,2-a]pyridine, 6-bromo-2,3-dimethyl-8-(phenylmethoxy)-
• CAS NO: 362525-67-5
• Molecular Formula: C16H15BrN2O
• Molecular Weight: 331.212
• Mol File: 362525-67-5.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: Imidazo[1,2-a]pyridine, 6-bromo-2,3-dimethyl-8-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,2-a]pyridine, 6-bromo-2,3-dimethyl-8-(phenylmethoxy)-(362525-67-5)
• EPA Substance Registry System: Imidazo[1,2-a]pyridine, 6-bromo-2,3-dimethyl-8-(phenylmethoxy)-(362525-67-5)

Safety Data

• Hazardous Substances Data: 362525-67-5(Hazardous Substances Data)

Upstream product

• 754230-78-9 3-(benzyloxy)-5-bromopyridine-2-amine 
• 814-75-5 3-bromo-butanone 
• 362525-66-4 6,8-Dibromo-2,3-dimethylimidazo[1,2-a]pyridine 
• 20194-18-7 sodium phenyl-methanolate 
• 100-51-6 benzyl alcohol 

Downstream Products

• 362525-68-6 8-benzyloxy-2,3-dimethylimidazo[1,2-a]pyridine-6-carboxylic acid ethyl ester 

Relevant articles and documents

Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase

A series of novel 8-indanylamino- and 8-indanyloxy-substituted imidazo[1,2-a]pyridines with reduced lipophilicity was synthesized from easily accessible starting compounds. The anti-secretory activity of these compounds has been assessed in a competitive

POLYSUBSTITUTED IMIDAZOPYRIDINES AS GASTRIC SECRETION INHIBITORS

The invention relates to imidazopyridines of a certain formula 1, in which the substituents and symbols have the meanings indicated in the description. The compounds have gastric secretion-inhibiting properties.

Prodrugs of imidazopyridine derivatives

Compounds of formula (1), in which the substituents have the meanings mentioned in the description are suitable for the prevention and treatment of gastrointestinal diseases.